Clare Lucker, MS&L: Drug focus turns to the few
By Clare Lucker, MS&L, prweek.com, 21 August 2009, 3:08pm
A shift from blockbuster to niche medicines means we need to talk to individuals, not the masses
Share this story
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.









